HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,013,425 | +101.6% | 85,633 | +87.1% | 0.02% | +122.2% |
| Q1 2023 | $1,494,417 | -80.1% | 45,771 | -66.5% | 0.01% | -79.5% |
| Q4 2022 | $7,527,156 | +101.4% | 136,609 | +61.9% | 0.04% | +109.5% |
| Q3 2022 | $3,737,000 | +215.1% | 84,386 | +247.0% | 0.02% | +200.0% |
| Q2 2022 | $1,186,000 | -74.3% | 24,317 | -74.3% | 0.01% | -82.1% |
| Q1 2022 | $4,611,000 | +151.4% | 94,787 | +120.4% | 0.04% | +129.4% |
| Q4 2021 | $1,834,000 | -12.4% | 43,000 | -21.3% | 0.02% | -34.6% |
| Q3 2021 | $2,094,000 | +276.6% | 54,633 | +177.5% | 0.03% | +333.3% |
| Q2 2021 | $556,000 | – | 19,686 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |